Display Settings:

Format

Send to:

Choose Destination
    Mol Cell Biol. 2005 Feb;25(4):1437-45.

    Normal immune system development in mice lacking the Deltex-1 RING finger domain.

    Source

    INSERM U373, Faculté de Médecine Necker-Enfants Malades, 75730 Paris, France.

    Abstract

    The Notch signaling pathway controls several cell fate decisions during lymphocyte development, from T-cell lineage commitment to the peripheral differentiation of B and T lymphocytes. Deltex-1 is a RING finger ubiquitin ligase which is conserved from Drosophila to humans and has been proposed to be a regulator of Notch signaling. Its pattern of lymphoid expression as well as gain-of-function experiments suggest that Deltex-1 regulates both B-cell lineage and splenic marginal-zone B-cell commitment. Deltex-1 was also found to be highly expressed in germinal-center B cells. To investigate the physiological function of Deltex-1, we generated a mouse strain lacking the Deltex-1 RING finger domain, which is essential for its ubiquitin ligase activity. Deltex-1(Delta/Delta) mice were viable and fertile. A detailed histological analysis did not reveal any defects in major organs. T- and B-cell development was normal, as were humoral responses against T-dependent and T-independent antigens. These data indicate that the Deltex-1 ubiquitin ligase activity is dispensable for mouse development and immune function. Possible compensatory mechanisms, in particular those from a fourth Deltex gene identified during the course of this study, are also discussed.

    PMID:
    15684394
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC548011
    Free PMC Article

    Images from this publication.See all images (6) Free text

    FIG. 1.
    FIG. 3.
    FIG. 5.
    FIG. 2.
    FIG. 4.
    FIG. 6.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk